ANZCTR search results

Selected patients with signs of pudendal neuralia and low back pain treated with physiotherapy consisting of mobilisation and exercises directed to the lumbar pelvic region.

This study investigates the effects of branched chain amino acids and/or Synbiotics, a mixture of probiotics and prebiotics, on the level of hepatic encephalopthy in patients with cirrhosis using using computerised psychometric test and trail making test It also investigates the effects of branched chain amino acids and/or Synbiotics, a mixture of probiotics and prebiotics, on inflammatory process, quality of life, frequency and duration of hospitalisation, food intake and body composition.

An Early Intervention Program which targets preschool aged children who are at a high risk of developing anxiety. Efficacy of the program will determine whether prevention steps in the early years have a part to play in reducing current symptoms and also associated risk.

The aim of the present study is to examine the efficacy of a group modified cognitive behavioural therapy (CBT) intervention on reducing anxiety and internalizing disorders in adolescents with high functioning autism spectrum disorder. In addition to a longitudinal follow-up, this study seeks to determine the impact this treatment has on family quality of life.

The purpose of the study is to answer three key research questions: 1. What effect does supervised, progressive resistance training (PRT) have on the number and incidence of falls in older adults with impaired balance? 2. What effect does supervised, PRT have on balance in older adults with impaired balance? 3. What effect does supervised, PRT have on self-reported quality of life of older adults with impaired balance?

This trial investigates the effect of hip surgery on sleep apnea severity. We hypothesise that sleep apnea will worsen in the immediate postoperative period, due to factors such as sedative medications, intubation and the requirement to lie on the back after surgery.

This is a nutrition program for women after breast cancer treatment, called The Muscle Mass, Omega-3, Diet, Exercise and Lifestyle (MODEL) Study. Who is it for? You can join this study if you are a woman who is a breast cancer survivor. In other words, you have successfully completed surgery, radiotherapy and/or chemotherapy with no sign of existing disease, and treatment was completed less than 12 months ago. You must be aged from 18 to 80 years. Trial details Participants will be randomly allocated to one of three groups. One group will take a nutritional supplement of 3g/day of Omega-3 fatty acids for 6 months. A second group will take Omega-3 in conjunction with 12 weeks of Cognitive Behavioural Therapy (CBT) healthy eating and exercise education. The third group will undergo the CBT program and take placebo capsules. Participants will be monitored at the start of the program and at 12 and 26 weeks. The study aims to measure any changes in lean body mass, changes in inflammation and changes in quality of life

Uveitis is a term that refers to inflammatory diseases of the eye. Uveitis accounts for about 10% of the legal blindness in developed countries such as Australia and the United States and is roughly comparable to diabetes in terms of years of visual loss. The most severe forms of uveitis have the highest risk of vision loss. One of the common causes of vision loss in uveitis is swelling of the central retina, or “macular oedema”. This is due to the abnormal leakage of fluid from blood vessels within the retina as a result of uncontrolled inflammation. Standard treatments for severe uveitis and associated complications like macular oedema include systemic medication or injections of long acting steroid into, or around the eye. Systemic treatments include steroid tablets or low doses of drugs that are also used in chemotherapy like cyclophosphamide or cyclosporine. These systemic treatments have significant associated side effects and therefore are not ideal, particularly in people who only have uveitis in one eye. Injections of a long acting steroid (triamcinolone) directly into the eye (“intra-vitreally”) is another established treatment modality for some types of uveitis and blinding complications like uveitic macular oedema, particularly in those with uveitis in only one eye. However, there are known side effects of this treatment such as cataract, glaucoma, infection (endophthalmitis) and retinal detatchment. Of these, cataract and glaucoma are by far the most common and, unlike the other complications, are the direct result of the effect of triamcinolone on the eye, rather than being a complication of the injection procedure. Although the visual loss from cataract may be reversed with cataract surgery, visual loss from glaucoma can only be halted with available treatments and not reversed. Therefore patients who have glaucoma, or are known to develop raised intraocular pressures in response to steroid treatment (such as triamcinolone), are not offered this treatment, thereby limiting the available options for the management of their uveitis and/or uveitic macular oedema. Methotrexate is a drug that has been used in chemotherapy but also in low doses to control inflammatory diseases like rheumatoid arthritis in both adults and children. More recently, it has also been used as an injection intravitreally to treat both ocular lymphoma as well as uveitis and uveitic macular oedema. Preliminary studies using methotrexate intravitreally as treatment for severe forms of uveitis and associated sight threatening complications like macular oedema appear promising, without the side effects known to be associated with steroid treatment such as cataract and glaucoma. We therefore have 2 specific aims: Aim 1: To prospectively evaluate the efficacy of intavitreal methotrexate in the treatment of active intermediate, posterior or panuveitis Aim 2: To prospectively evaluate the efficacy of intravitreal methotrexate in the treatment of uveitic macular oedema

Preterm babies with breathing troubles are routinely supported by the use of continuous positive airway pressure (CPAP) via nasal prongs that require taping to the infant’s face and a bonnet to maintain an adequate seal and to keep the prongs in position. This can restrict care, parent-infant cuddles and breast feeding. The prongs also occlude the nose and sometimes cause damage to the nasal septum. Weaning an infant from CPAP may take weeks or months. This is a randomised controlled trial of 2 methods of weaning CPAP support (abrupt or gradual), combined with the use of Heated Humidified High Flow Nasal Cannula (HHFNC) devices or not, making four arms / groups. The purpose of the study is to determine which method of weaning from CPAP is most effective at reducing the length of hospital stay, facilitating infant suck feeding and parent-infant interaction and reducing the intensity of nursing care.

Research in bipolar disorder has suggested that recovery from the illness consists of a three-pronged approach involving medication, information/education about the disorder, and having a plan or strategy to remain well. The current study combines the latter two psychosocial approaches to recovery in bipolar disorder into one intervention. It aims to examine the efficacy of an 8-session group psychoeducation program for adults recently diagnosed with bipolar II disorder that incorporates the development of an individualised comprehensive wellbeing plan across sessions.